These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15219462)
1. Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene. Moon BG; Takaki S; Nishizumi H; Yamamoto T; Takatsu K Cell Immunol; 2004 Apr; 228(2):110-8. PubMed ID: 15219462 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML J Immunol; 2010 Feb; 184(3):1348-60. PubMed ID: 20042579 [TBL] [Abstract][Full Text] [Related]
3. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene. Takeshita H; Taniuchi I; Kato J; Watanabe T Int Immunol; 1998 Apr; 10(4):435-44. PubMed ID: 9620599 [TBL] [Abstract][Full Text] [Related]
4. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development. Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664 [TBL] [Abstract][Full Text] [Related]
5. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency. Verhagen AM; Wallace ME; Goradia A; Jones SA; Croom HA; Metcalf D; Collinge JE; Maxwell MJ; Hibbs ML; Alexander WS; Hilton DJ; Kile BT; Starr R J Immunol; 2009 Feb; 182(4):2020-9. PubMed ID: 19201855 [TBL] [Abstract][Full Text] [Related]
7. CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice. Oracki SA; Tsantikos E; Quilici C; Light A; Schmidt T; Lew AM; Martin JE; Smith KG; Hibbs ML; Tarlinton DM J Immunol; 2010 Jan; 184(2):757-63. PubMed ID: 19966213 [TBL] [Abstract][Full Text] [Related]
8. Regulation of B-1 cell activation and its autoantibody production by Lyn kinase-regulated signallings. Ochi H; Takeshita H; Suda T; Nisitani S; Honjo T; Watanabe T Immunology; 1999 Dec; 98(4):595-603. PubMed ID: 10594694 [TBL] [Abstract][Full Text] [Related]
9. Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice. Tsantikos E; Quilici C; Harder KW; Wang B; Zhu HJ; Anderson GP; Tarlinton DM; Hibbs ML J Immunol; 2009 Aug; 183(4):2484-94. PubMed ID: 19620313 [TBL] [Abstract][Full Text] [Related]
10. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. Gutierrez T; Mayeux JM; Ortega SB; Karandikar NJ; Li QZ; Rakheja D; Zhou XJ; Satterthwaite AB Eur J Immunol; 2013 Feb; 43(2):382-93. PubMed ID: 23169140 [TBL] [Abstract][Full Text] [Related]
11. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Nishizumi H; Taniuchi I; Yamanashi Y; Kitamura D; Ilic D; Mori S; Watanabe T; Yamamoto T Immunity; 1995 Nov; 3(5):549-60. PubMed ID: 7584145 [TBL] [Abstract][Full Text] [Related]
12. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice. Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486 [TBL] [Abstract][Full Text] [Related]
13. Genetic evidence for Lyn as a negative regulator of IL-4 signaling. Janas ML; Hodgkin P; Hibbs M; Tarlinton D J Immunol; 1999 Oct; 163(8):4192-8. PubMed ID: 10510355 [TBL] [Abstract][Full Text] [Related]
15. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice. Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339 [TBL] [Abstract][Full Text] [Related]
16. B cell-specific loss of Lyn kinase leads to autoimmunity. Lamagna C; Hu Y; DeFranco AL; Lowell CA J Immunol; 2014 Feb; 192(3):919-28. PubMed ID: 24376269 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival. Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813 [TBL] [Abstract][Full Text] [Related]
18. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease. Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336 [TBL] [Abstract][Full Text] [Related]
19. Cutting Edge: Deletion of Ezrin in B Cells of Lyn-Deficient Mice Downregulates Lupus Pathology. Pore D; Huang E; Dejanovic D; Parameswaran N; Cheung MB; Gupta N J Immunol; 2018 Sep; 201(5):1353-1358. PubMed ID: 30021765 [TBL] [Abstract][Full Text] [Related]
20. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. Hibbs ML; Harder KW; Armes J; Kountouri N; Quilici C; Casagranda F; Dunn AR; Tarlinton DM J Exp Med; 2002 Dec; 196(12):1593-604. PubMed ID: 12486102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]